Amgen Inc.

(NASDAQ:AMGN)

56.34

-1.13 (-1.97%)

Dec 04 - Close

Open
High
57.59
Low
56.00
Vol.
8.21M
Mkt Cap
60.89B
52Wk High
66.51
52Wk Low
39.16
Avg. Vol.
10.76M
P/E (Trailing)
14.98
Beta
0.68
Short %
2.30%
Div. Yield

After-Hours 56.65 +0.31 (0.55%) Thu, 4 Dec 2008 7:40 PM

Company Profile

Amgen Inc.

One Amgen Center Drive

Thousand Oaks, CA 91320-1799

United States - Map

Phone: (805) 447-1000

Fax: (805) 447-1010

Website: www.amgen.com

State of incorporation: Delaware

CEO: Kevin W. Sharer

Employees: 17,400

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Research/dev of biological products using DNA

A biotechnology company, which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Recent opinions on AMGN

No recent Opinions for AMGN

Top members owning AMGN

Members owning AMGN also own

GE (21.21%), CL (18.18%), KO (18.18%), AIG (15.15%), MON (15.15%)

Member sentiment: Neutral